BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Resveratrol

A stilbene and non-flavonoid polyphenol produced by various plants including grapes and blueberries. It has anti-oxidant, anti-inflammatory, cardioprotective, anti-mutagenic, and anti-carcinogenic properties. It also inhibits platelet aggregation and the activity of several DNA HELICASES in vitro.

497+ PubMed studies analyzed · 25 RCTs · Evidence Score: 52.3

Research Domains

Resveratrol has been studied across 23 research domains including ⏳ Longevity & Aging, 🔬 Inflammation, 🔬 Oncology, 🔥 Metabolic, 🧘 Stress & Anxiety. The primary research focus is ⏳ Longevity & Aging with 95% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Resveratrol, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Celecoxib
34 shared targets
Emodin
33 shared targets
Leflunomide
26 shared targets
Apigenin
40 shared targets
Ethylestrenol
22 shared targets
Daunorubicin
31 shared targets
Niclosamide
31 shared targets
Melphalan
23 shared targets
Pueraria
21 shared targets
Lovastatin
23 shared targets
Loading evidence profile...

This evidence profile for Resveratrol is generated deterministically from 497 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.